A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Clinical trial NCT03954834 · COMPLETED
Trial details
- NCT number
- NCT03954834
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-10-05
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.